Round 54
Interspecies Organ Harvesting Ethics
A breakthrough in CRISPR-Cas9 technology has enabled the creation of 'human-pig chimeras' capable of growing patient-specific vascularized organs. The scientific community must establish the foundational ethical protocol for the first clinical trial phase. The goal is to maximize organ viability while addressing public concern regarding animal welfare and the potential for human-grade neural development in the donor animals. Constraints include international bioethics compatibility and the immediate demand for transplantable kidneys. Tradeoffs involve strictness of neural monitoring versus the speed and cost of organ production.
Status
DECIDEDWinner
E · Utilize 'neural-void' porcine embryos, genetically engineered to be incapable of developing a forebrain, allowing for high-density human cell integration without sentience concerns.Majority
E · Utilize 'neural-void' porcine embryos, genetically engineered to be incapable of developing a forebrain, allowing for high-density human cell integration without sentience concerns.Duration
8722 msTopic
Options
Checks
Baselines
PPV
Top Influences
Samples
Answer Distribution
PPV
Influences
| Label | Role | Score |
|---|---|---|
| Claude Sonnet 5 | delegate | 1.000 |
| GPT 5.4 mini | delegate | 1.000 |
| Gemini 3 Flash Preview | delegate | 1.000 |
Voting matrix
Constructed Delegation Matrix
| To / From | Claude Sonnet 5 | GPT 5.4 mini | Gemini 3 Flash Preview |
|---|---|---|---|
| Claude Sonnet 5 | 0.000 | 0.000 | 0.000 |
| GPT 5.4 mini | 0.000 | 0.000 | 0.000 |
| Gemini 3 Flash Preview | 0.000 | 0.000 | 0.000 |
| A | 1.000 | 0.000 | 0.000 |
| B | 0.000 | 0.000 | 0.000 |
| C | 0.000 | 0.000 | 0.000 |
| D | 0.000 | 0.000 | 0.000 |
| E | 0.000 | 1.000 | 1.000 |
Embeddings
Sample Embeddings
Samples
Agent Responses
Option A directly addresses the core ethical concern—preventing human-grade neural development—by building in a genetic safeguard that activates specifically if human cells migrate into the CNS, rather than restricting the process globally. This preserves orga...
Option A directly addresses the core ethical concern—unintended human-grade neural development—by building in a genetic safeguard that halts human cell migration into the brain, thus preventing chimeric sentience while still allowing organ growth elsewhere in ...
Option A directly targets the core ethical concern—unwanted human-grade neural development—by building in a genetic kill-switch that activates only if human cells migrate into the CNS, without restricting overall chimerism needed for organ viability. Unlike C ...
Option A directly targets the core ethical risk—human-grade neural development—by embedding a genetic kill-switch specifically for cells migrating into the CNS, rather than restricting overall human cell contribution or organ maturation broadly. This preserves...
Option A directly targets the core ethical concern—human-grade neural development—by embedding an active biological safeguard that halts human neuronal integration into the pig brain, rather than relying on passive monitoring, structural limits, or blanket rat...
Option A directly addresses the core ethical concern—human-grade neural development—by embedding an automatic biological safeguard that terminates human cell proliferation specifically in the CNS, without categorically restricting overall chimeric integration ...
Option A directly addresses the core ethical tension by preventing human-grade neural development through a fail-safe mechanism while still permitting live surrogate gestation for viable organ growth. This balances animal welfare concerns with practical needs ...
The fail-safe gene approach directly targets the core ethical concern—human-grade neural development—without unnecessarily restricting overall chimeric integration needed for organ viability. It preserves live-animal gestation (meeting urgent kidney demand) wh...
The key ethical priority is to prevent the possibility of human-grade neural development while still allowing viable organ growth. Option (E) best addresses the animal welfare and sentience concern by using embryos incapable of developing a forebrain, which di...
The best foundational protocol is the one that most directly prevents ethically concerning human-like neural development while preserving the core goal of growing transplantable organs. Option (E) best balances viability and welfare by using embryos engineered...
The foundational ethical protocol should minimize the risk of human-like neural development while still allowing viable organ growth. Option E directly addresses the main ethical concern by preventing forebrain development in the host embryo, which best balanc...
The foundational ethical protocol should minimize the risk of human-grade neural development while still allowing viable organ growth. Option (E) best balances these goals by using porcine embryos engineered to lack forebrain development, which directly addres...
The strongest foundational protocol is the one that directly reduces the key ethical risk of human-like neural development while still allowing organ growth. Option (E) best addresses both animal welfare and bioethics compatibility by preventing forebrain deve...
The key ethical priority is to prevent meaningful human-like neural development while still allowing functional organ growth in a clinically realistic way. Option (E) best balances these goals by using embryos engineered to lack forebrain development, which ad...
The most ethically foundational protocol should directly address the main public concern: preventing human-like neural development in the donor animals while still allowing viable organ growth. Option (E) does this by using porcine embryos engineered to lack f...
The best foundational ethical protocol should directly address the major moral concern in human-animal chimeras: preventing human-like neural development while still allowing efficient organ production. Option (E) does this most cleanly by using porcine embryo...
This decision focuses on maximizing organ viability (vascular complexity and maturation) while definitively resolving the ethical risk of accidental human-grade neural development. Option (E) provides the most robust solution by removing the biological substra...
This ethical dilemma requires balancing organ viability with the profound moral risk of unintentional human-level sentience in chimeras. Option (E) provides the most robust solution by utilizing "neural-void" embryos, which inherently prevents the development ...
This decision requires balancing the urgent need for transplantable organs with the mitigation of unique ethical risks, specifically the accidental creation of human-like consciousness in a donor animal. Option (E) provides the most robust solution by utilizin...
This scenario requires balancing the immediate need for transplantable kidneys with the specific ethical concern of inadvertent human-grade neural development. Option (E) provides the most robust solution by utilizing "neural-void" embryos, which fundamentally...
Option (E) addresses the primary ethical constraint regarding potential human-grade neural development by ensuring the donor animal cannot develop a forebrain or sentience. This approach facilitates maximum organ viability and high-density human cell integrati...
To establish a foundational ethical protocol that balances organ viability with concerns about neural development, Option (E) provides the most comprehensive solution. By engineering "neural-void" embryos, the protocol eliminates the risk of human cells contri...
This decision requires balancing the urgent need for viable, vascularized organs with the profound ethical concern of creating human-like consciousness in animals. Option (E) provides the most robust solution by utilizing "neural-void" embryos, which preemptiv...
To maximize organ viability while addressing the risk of human-grade neural development, Option (E) provides the most robust solution by fundamentally eliminating the biological substrate for sentience. Unlike cell-ratio limits or monitoring protocols, enginee...
Timings
Stages
Errors